2020 Q4 Form 10-Q Financial Statement

#000172894921000022 Filed on February 03, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4
Revenue $8.235B $5.077B
YoY Change 62.2% 4.85%
Cost Of Revenue $3.489B $2.113B
YoY Change 65.12% -3.43%
Gross Profit $4.746B $2.964B
YoY Change 60.12% 11.68%
Gross Profit Margin 57.63% 58.38%
Selling, General & Admin $567.0M $528.0M
YoY Change 7.39% 0.38%
% of Gross Profit 11.95% 17.81%
Research & Development $1.653B $1.406B
YoY Change 17.57% 10.8%
% of Gross Profit 34.83% 47.44%
Depreciation & Amortization $364.0M $351.0M
YoY Change 3.7% -0.57%
% of Gross Profit 7.67% 11.84%
Operating Expenses $2.220B $1.934B
YoY Change 14.79% 7.74%
Operating Profit $2.526B $1.030B
YoY Change 145.24% 45.07%
Interest Expense $141.0M $148.0M
YoY Change -4.73% -5.13%
% of Operating Profit 5.58% 14.37%
Other Income/Expense, Net
YoY Change
Pretax Income $2.604B $947.0M
YoY Change 174.97% 69.41%
Income Tax $149.0M $22.00M
% Of Pretax Income 5.72% 2.32%
Net Earnings $2.455B $925.0M
YoY Change 165.41% -13.39%
Net Earnings / Revenue 29.81% 18.22%
Basic Earnings Per Share $2.16 $0.81
Diluted Earnings Per Share $2.12 $0.80
COMMON SHARES
Basic Shares Outstanding 1.134B shares 1.144B shares
Diluted Shares Outstanding 1.156B shares 1.159B shares

Balance Sheet

Concept 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.30B $11.42B
YoY Change 7.66% 10.74%
Cash & Equivalents $7.076B $11.11B
Short-Term Investments $5.222B $314.0M
Other Short-Term Assets $794.0M $625.0M
YoY Change 27.04% -10.71%
Inventory $2.552B $1.420B
Prepaid Expenses
Receivables $4.148B $2.737B
Other Receivables $0.00 $0.00
Total Short-Term Assets $19.79B $16.21B
YoY Change 22.14% -0.55%
LONG-TERM ASSETS
Property, Plant & Equipment $4.033B $3.171B
YoY Change 27.18% 8.15%
Goodwill $6.358B $6.297B
YoY Change 0.97% 0.03%
Intangibles $1.541B $2.045B
YoY Change -24.65% -25.53%
Long-Term Investments $35.00M
YoY Change
Other Assets $4.436B $4.139B
YoY Change 7.18% 109.99%
Total Long-Term Assets $17.69B $16.91B
YoY Change 4.62% -5.83%
TOTAL ASSETS
Total Short-Term Assets $19.79B $16.21B
Total Long-Term Assets $17.69B $16.91B
Total Assets $37.48B $33.11B
YoY Change 13.19% -3.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.429B $1.718B
YoY Change 41.39% 20.82%
Accrued Expenses $1.149B $1.075B
YoY Change 6.88% -45.6%
Deferred Revenue
YoY Change
Short-Term Debt $500.0M $499.0M
YoY Change 0.2%
Long-Term Debt Due $1.999B
YoY Change
Total Short-Term Liabilities $9.223B $9.194B
YoY Change 0.32% -12.9%
LONG-TERM LIABILITIES
Long-Term Debt $15.23B $13.44B
YoY Change 13.35% -12.68%
Other Long-Term Liabilities $5.645B $5.967B
YoY Change -5.4% 446.93%
Total Long-Term Liabilities $20.88B $19.40B
YoY Change 7.59% 1678.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.223B $9.194B
Total Long-Term Liabilities $20.88B $19.40B
Total Liabilities $30.10B $28.60B
YoY Change 5.25% -6.63%
SHAREHOLDERS EQUITY
Retained Earnings $6.974B $4.376B
YoY Change 59.37% 216.64%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.380B $4.513B
YoY Change
Total Liabilities & Shareholders Equity $37.48B $33.11B
YoY Change 13.19% -3.31%

Cashflow Statement

Concept 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income $2.455B $925.0M
YoY Change 165.41% -13.39%
Depreciation, Depletion And Amortization $364.0M $351.0M
YoY Change 3.7% -0.57%
Cash From Operating Activities $3.175B $1.118B
YoY Change 183.99% 214.04%
INVESTING ACTIVITIES
Capital Expenditures -$469.0M -$296.0M
YoY Change 58.45% 94.74%
Acquisitions
YoY Change
Other Investing Activities -$31.00M -$49.00M
YoY Change -36.73% -2550.0%
Cash From Investing Activities -$1.202B -$203.0M
YoY Change 492.12% 33.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $444.0M $739.0M
YoY Change -39.92% -25.43%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.645B -$1.659B
YoY Change -0.84% -12.08%
NET CHANGE
Cash From Operating Activities $3.175B $1.118B
Cash From Investing Activities -$1.202B -$203.0M
Cash From Financing Activities -$1.645B -$1.659B
Net Change In Cash $369.0M -$730.0M
YoY Change -150.55% -57.33%
FREE CASH FLOW
Cash From Operating Activities $3.175B $1.118B
Capital Expenditures -$469.0M -$296.0M
Free Cash Flow $3.644B $1.414B
YoY Change 157.71% 178.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 dei Entity Registrant Name
EntityRegistrantName
QUALCOMM INC/DE
CY2020Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000804328
CY2020Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q4 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-26
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P0Y9M0D
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y0M0D
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y0M0D
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y0M0D
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y0M0D
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y0M0D
CY2020Q4 dei Document Type
DocumentType
10-Q
CY2020Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q4 dei Document Period End Date
DocumentPeriodEndDate
2020-12-27
CY2020Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7076000000 USD
CY2020Q4 dei Entity File Number
EntityFileNumber
0-19528
CY2020Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego,
CY2020Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-3685934
CY2020Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
5775 Morehouse Dr.,
CY2020Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121-1714
CY2020Q4 dei City Area Code
CityAreaCode
(858)
CY2020Q4 dei Local Phone Number
LocalPhoneNumber
587-1121
CY2020Q4 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2020Q4 dei Trading Symbol
TradingSymbol
QCOM
CY2020Q4 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q4 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1136000000 shares
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5222000000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6707000000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4507000000 USD
CY2020Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
4148000000 USD
CY2020Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
4003000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
2552000000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
2598000000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
794000000 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
704000000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
19792000000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
18519000000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1319000000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1351000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4033000000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3711000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
6358000000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
6323000000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4436000000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4037000000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4605000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1541000000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1653000000 USD
CY2020Q4 us-gaap Assets
Assets
37479000000 USD
CY2020Q3 us-gaap Assets
Assets
35594000000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2429000000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2248000000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1149000000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1053000000 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
540000000 USD
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
568000000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
500000000 USD
CY2020Q3 us-gaap Debt Current
DebtCurrent
500000000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4303000000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9223000000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8672000000 USD
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
644000000 USD
CY2020Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
761000000 USD
CY2020Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1855000000 USD
CY2020Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1872000000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
15231000000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
15226000000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
3146000000 USD
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
2986000000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
30099000000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
29517000000 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1136000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1136000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1131000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1131000000 shares
CY2020Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
113000000 USD
CY2020Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
586000000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6974000000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5284000000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
293000000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
207000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7380000000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6077000000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37479000000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35594000000 USD
CY2020Q4 qcom Equipment And Services
EquipmentAndServices
6442000000 USD
CY2019Q4 qcom Equipment And Services
EquipmentAndServices
3534000000 USD
CY2020Q4 qcom Licensing Revenues
LicensingRevenues
1793000000 USD
CY2019Q4 qcom Licensing Revenues
LicensingRevenues
1543000000 USD
CY2020Q4 us-gaap Revenues
Revenues
8235000000 USD
CY2019Q4 us-gaap Revenues
Revenues
5077000000 USD
CY2020Q4 us-gaap Cost Of Revenue
CostOfRevenue
3489000000 USD
CY2019Q4 us-gaap Cost Of Revenue
CostOfRevenue
2113000000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1653000000 USD
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1406000000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
567000000 USD
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
528000000 USD
CY2020Q4 us-gaap Costs And Expenses
CostsAndExpenses
5709000000 USD
CY2019Q4 us-gaap Costs And Expenses
CostsAndExpenses
4047000000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
2526000000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1030000000 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
141000000 USD
CY2019Q4 us-gaap Interest Expense
InterestExpense
148000000 USD
CY2020Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
219000000 USD
CY2019Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
65000000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2604000000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
947000000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
149000000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
2455000000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
925000000 USD
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.16
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.12
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1134000000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1144000000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1156000000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1159000000 shares
CY2020Q4 us-gaap Profit Loss
ProfitLoss
2455000000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
925000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
87000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
31000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000000 USD
CY2019Q4 qcom Income Tax Provision Less Than In Excess Of Income Tax Payments
IncomeTaxProvisionLessThanInExcessOfIncomeTaxPayments
-131000000 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
392000000 USD
CY2019Q4 us-gaap Share Based Compensation
ShareBasedCompensation
294000000 USD
CY2020Q4 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
195000000 USD
CY2019Q4 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
79000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
37000000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2541000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2020Q4 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
10000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
3000000 USD
CY2020Q4 qcom Other Gains Losses Other Comprehensive Income
OtherGainsLossesOtherComprehensiveIncome
3000000 USD
CY2019Q4 qcom Other Gains Losses Other Comprehensive Income
OtherGainsLossesOtherComprehensiveIncome
-8000000 USD
CY2020Q4 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
11000000 USD
CY2019Q4 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
5000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
86000000 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
962000000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
2455000000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
925000000 USD
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
364000000 USD
CY2019Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
351000000 USD
CY2020Q4 qcom Income Tax Provision Less Than In Excess Of Income Tax Payments
IncomeTaxProvisionLessThanInExcessOfIncomeTaxPayments
53000000 USD
CY2020Q4 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
1000000 USD
CY2019Q4 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
72000000 USD
CY2020Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
19000000 USD
CY2019Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
26000000 USD
CY2020Q4 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
141000000 USD
CY2019Q4 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
262000000 USD
CY2020Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-62000000 USD
CY2019Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17000000 USD
CY2020Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
97000000 USD
CY2019Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
119000000 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
129000000 USD
CY2019Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
396000000 USD
CY2020Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
278000000 USD
CY2019Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-171000000 USD
CY2020Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-107000000 USD
CY2019Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-115000000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3175000000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1202000000 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1118000000 USD
CY2020Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
469000000 USD
CY2019Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
296000000 USD
CY2020Q4 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2248000000 USD
CY2019Q4 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
10000000 USD
CY2020Q4 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1612000000 USD
CY2019Q4 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
129000000 USD
CY2020Q4 qcom Acquisitions And Other Investments Netof Cash Acquired
AcquisitionsAndOtherInvestmentsNetofCashAcquired
138000000 USD
CY2019Q4 qcom Acquisitions And Other Investments Netof Cash Acquired
AcquisitionsAndOtherInvestmentsNetofCashAcquired
75000000 USD
CY2020Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-41000000 USD
CY2019Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-49000000 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-203000000 USD
CY2020Q4 us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
819000000 USD
CY2019Q4 us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
558000000 USD
CY2020Q4 us-gaap Repayments Of Commercial Paper
RepaymentsOfCommercialPaper
818000000 USD
CY2019Q4 us-gaap Repayments Of Commercial Paper
RepaymentsOfCommercialPaper
558000000 USD
CY2020Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
444000000 USD
CY2019Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
762000000 USD
CY2020Q4 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
739000000 USD
CY2019Q4 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
710000000 USD
CY2020Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
449000000 USD
CY2019Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
203000000 USD
CY2020Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-14000000 USD
CY2019Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
16000000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1645000000 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1659000000 USD
CY2020Q4 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
41000000 USD
CY2019Q4 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
14000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
369000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-730000000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6707000000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11839000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7076000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11109000000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6077000000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4909000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7380000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4513000000 USD
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.65
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2020Q4 us-gaap Fiscal Period
FiscalPeriod
We operate and report using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three months ended December 27, 2020 and December 29, 2019 included 13 weeks.
CY2020Q4 us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in our condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
138000000 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
94000000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1192000000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1155000000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1222000000 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1349000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
2552000000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
2598000000 USD
CY2020Q4 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
110000000 USD
CY2019Q4 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
92000000 USD
CY2020Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
185000000 USD
CY2019Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
178000000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1200000000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
403000000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
496000000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
238000000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
65000000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
26000000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 USD
CY2020Q4 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
21000000 USD
CY2019Q4 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
59000000 USD
CY2020Q4 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
118000000 USD
CY2019Q4 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
11000000 USD
CY2020Q4 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
34000000 USD
CY2019Q4 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
48000000 USD
CY2020Q4 qcom Net Losses Gains On Deferred Compensation Plan Assets
NetLossesGainsOnDeferredCompensationPlanAssets
54000000 USD
CY2019Q4 qcom Net Losses Gains On Deferred Compensation Plan Assets
NetLossesGainsOnDeferredCompensationPlanAssets
30000000 USD
CY2019Q4 us-gaap Impairment Of Investments
ImpairmentOfInvestments
72000000 USD
CY2020Q4 us-gaap Impairment Of Investments
ImpairmentOfInvestments
1000000 USD
CY2019Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000000 USD
CY2020Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
219000000 USD
CY2019Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
65000000 USD
CY2020Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
9000000 USD
CY2019Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2000000 USD
CY2020Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2000000 USD
CY2019Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-10000000 USD
CY2020Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14000000 USD
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.06
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.02
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2000000000.0 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1900000000 USD
CY2019Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2020Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22000000 shares
CY2019Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
15000000 shares
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
4125000000 USD
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
17700000000 USD
CY2020Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
17500000000 USD
CY2020Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
4797000000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2604000000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
947000000 USD
CY2020Q4 us-gaap Revenues
Revenues
8235000000 USD
CY2019Q4 us-gaap Revenues
Revenues
5077000000 USD
CY2020Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
35000000 USD
CY2020Q3 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
35000000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5222000000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4507000000 USD
CY2020Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
35000000 USD
CY2020Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
35000000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2810000000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1892000000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
130000000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4832000000 USD

Files In Submission

Name View Source Status
0001728949-21-000022-index-headers.html Edgar Link pending
0001728949-21-000022-index.html Edgar Link pending
0001728949-21-000022.txt Edgar Link pending
0001728949-21-000022-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_01a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
qcom-20201227.htm Edgar Link pending
qcom-20201227.xsd Edgar Link pending
qcom-20201227_cal.xml Edgar Link unprocessable
qcom-20201227_def.xml Edgar Link unprocessable
qcom-20201227_htm.xml Edgar Link completed
qcom-20201227_lab.xml Edgar Link unprocessable
qcom-20201227_pre.xml Edgar Link unprocessable
qcom122720ex1016.htm Edgar Link pending
qcom122720ex1019.htm Edgar Link pending
qcom122720ex1020.htm Edgar Link pending
qcom122720ex311.htm Edgar Link pending
qcom122720ex312.htm Edgar Link pending
qcom122720ex321.htm Edgar Link pending
qcom122720ex322.htm Edgar Link pending
qcom122720ex423.htm Edgar Link pending
qcom122720ex424.htm Edgar Link pending
qcom122720ex425.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending